Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,942
Closed -$370K 1459
2022
Q4
$370K Buy
+4,942
New +$352K 0.01% 831
2022
Q1
Sell
-4,523
Closed -$346K 1389
2021
Q4
$346K Buy
+4,523
New +$332K 0.01% 798
2021
Q3
Sell
-63,220
Closed -$4.22M 1411
2021
Q2
$4.22M Buy
+63,220
New +$4.23M 0.1% 252
2021
Q1
Sell
-53,214
Closed -$3.88M 910
2020
Q4
$3.88M Buy
53,214
+48,014
+923% +$3.39M 0.13% 170
2020
Q3
$346K Buy
+5,200
New +$329K 0.05% 299

Other funds holding HOLX

Ergoteles's HOLX Position: Q1 2023 in Review

Ergoteles sold out of Hologic (HOLX) in Q1 2023, closing a stake of 4,942 shares — an estimated $370K sold.

Ergoteles first reported a position in HOLX in Q3 2020 and held it in 5 quarters. The position peaked at $4.22M in Q2 2021. 707 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

  • Ergoteles reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 4,942 Hologic shares in Q1 2023, an estimated $370K.
  • Ergoteles first reported a position in Hologic in Q3 2020 and held it in 5 quarters.
  • Ergoteles's Hologic position peaked at $4.22M in Q2 2021.
  • 707 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.